Claude Ranoux News Today

INVO | Complete INVO BioScience Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Shares of INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) were down 15.1% during mid-day trading on Wednesday . The company traded as low as $0.23 and last traded at $0.25. Approximately 141,229 shares traded hands during trading, an increase of 6% from the average daily volume of 132,667 shares. The stock had previously closed at […]

IRhythm Technologies (NASDAQ:IRTC – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Analyst Ratings This is a breakdown of recent ratings and […]

INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) shares were down 11.5% during mid-day trading on Tuesday . The stock traded as low as $0.45 and last traded at $0.45. Approximately 76,943 shares changed hands during mid-day trading, a decline of 54% from the average daily volume of 167,283 shares. The stock had previously closed at […]

INVO Bioscience (NASDAQ:INVO – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday, Zacks.com reports. The firm currently has a $1.25 target price on the stock. Zacks Investment Research‘s target price would indicate a potential upside of 16.28% from the stock’s current […]

INVO Bioscience (NASDAQ:INVO – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. […]

Zacks Investment Research upgraded shares of INVO Bioscience (NASDAQ:INVO – Get Rating) from a hold rating to a buy rating in a report issued on Friday morning, Zacks.com reports. They currently have $2.25 price objective on the stock. According to Zacks, “INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating […]

INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 42,200 shares, a decline of 44.2% from the January 31st total of 75,600 shares. Based on an average trading volume of 43,700 shares, the […]